Historical record - last NADAC effective date: 5/21/2014
Product Information
PV FLU RELIEF THERAPY LIQUID is a generic product labeled by Chain Drug Marketing Association, priced at $0.0121 per ML under NDC 68016015408. Its NADAC has been published 48 times since Nov 28, 2013.
Strength
325; 12.5; 5 mg/15mL; mg/15mL; mg/15mL
Manufacturer
Chain Drug Marketing AssociationNDC
68016015408
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
5/21/2014
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
10/4/2013
Pharmacological Classes
Price Statistics
The NADAC for PV FLU RELIEF THERAPY LIQUID has been published 48 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0121 per ML |
|---|---|
| All-time high | $0.0121 (May 14, 2014) |
| All-time low | $0.0120 (Nov 28, 2013) |
| Median price | $0.0121 |
| Average price | $0.0121 |
| Largest weekly change | +0.6% (Feb 19, 2014) |
| Weeks tracked | 48 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+0.7%
Last surveyed Nov 19, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chain Drug Marketing Association manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PV FLU RELIEF THERAPY LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for PV FLU RELIEF THERAPY LIQUID, manufactured by Chain Drug Marketing Association, is $0.0121 per ML (NDC 68016015408), effective Nov 19, 2014.
How has the price of PV FLU RELIEF THERAPY LIQUID changed over time?
Over the history we have for it, the NADAC for PV FLU RELIEF THERAPY LIQUID has held within roughly two percent of its current level. It has been tracked across 48 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PV FLU RELIEF THERAPY LIQUID?
Since Nov 28, 2013, the NADAC for PV FLU RELIEF THERAPY LIQUID has ranged from a low of $0.0120 (Nov 28, 2013) to a high of $0.0121 (May 14, 2014), with a median of $0.0121 per ML.
Are there cheaper alternatives to PV FLU RELIEF THERAPY LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of PV FLU RELIEF THERAPY LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PV FLU RELIEF THERAPY LIQUID?
PV FLU RELIEF THERAPY LIQUID (NDC 68016015408) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.